Why DSP Mutual Fund's Chirag Dagli is betting on CDMO, hospitals and smallcap healthcare stocks
DSP Mutual Fund is making a strategic shift in its healthcare portfolio, moving beyond traditional pharma to focus on Contract Development and Manufacturing Organizations (CDMOs). The fund manager, Chirag Dagli, believes these companies are well-positioned to benefit from the growing trend of global drug manufacturing outsourcing. This pivot reflects a broader confidence in the domestic healthcare ecosystem's ability to drive long-term value.
For investors, this signals a potential re-rating of the sector as valuations adjust to favor high-growth, niche segments. While the fund is also evaluating opportunities in hospital expansion and hybrid diagnostics, the primary focus remains on identifying companies with strong growth fundamentals. This strategy aims to capture the upside from India's rising healthcare consumption and manufacturing capabilities.
Investors should watch how the fund navigates the current market valuations. As the fund manager seeks to identify companies capable of sustaining growth, keeping an eye on the performance of small-cap healthcare stocks will be crucial. This move highlights the evolving nature of healthcare investing, where adaptability and sector-specific expertise are becoming increasingly important.
Key takeaways
- Category: Sector.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.










